Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269642 | HPB | 2011 | 9 Pages |
Abstract
Under the Model for Endâstage Liver Disease (MELD) system, in patients with HCC within the Milan Criteria, POLT increases survival and QoL at decreased costs compared with HR or LRT followed by SOLT. Therefore, POLT is the most costâeffective strategy for the treatment of HCC.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Matthew P. Landman, Irene D. Feurer, C. Wright Pinson, Derek E. Moore,